WILMINGTON, N.C, March 9, 2023 /PRNewswire/ — Alcami Company (“Alcami”), a top agreement development and production corporation (CDMO), right now introduced the appointment of Jamie Iudica to Main Producing Officer.
Jamie provides more than 25 yrs of experience in the pharmaceutical market, such as leadership roles in engineering, manufacturing, and offer chain operations. Prior to joining Alcami, Jamie was Chief Production Officer at Istari Oncology. He has served several production and operations management roles during his profession together with executive roles at Xellia Prescription drugs, Pfizer, and Hospira.
“Jamie’s extensive skills in drug product production operations will be integral as we grow the Alcami producing and functions footprint,” commented Patrick Walsh, Chairman and Main Govt Officer at Alcami Company.
Following an excellent 40-12 months job spanning all aspects of the pharmaceutical sector, Alcami Main Operations Officer Ken Domagalski has declared his intention to retire later this 12 months.
Ken has been instrumental in the style and construct out of Alcami’s sterile manufacturing amenities and played a critical role in the growth of the firm. He has led several prosperous Fda and global regulatory inspections over the training course of his career, managed pharmaceutical organizations all-around the globe, and the Alcami team has been honored to operate together with Ken.
“We are thankful for the company and management Ken has furnished through his tenure with Alcami and would like him the very best as he transitions to retirement,” commented Patrick.
As Chief Production Officer, Jamie will suppose Ken’s tasks for Alcami’s extensive drug solution production functions that supply medical to industrial sterile and oral stable dose enhancement and producing products and services. Jamie holds both of those a B.A. in Chemical Engineering and an MBA from Villanova University in Villanova, PA.
About Alcami Corporation
Alcami is a deal development and production group headquartered in North Carolina with above 40 several years of practical experience advancing products and solutions as a result of every phase of the advancement lifecycle. Leveraging 675,000 ft² throughout five US-dependent scientific campuses, Alcami serves pharmaceutical and biotech corporations of all sizes for little molecules and biologics, offering customizable and innovative remedies for analytical development, medical to professional sterile and oral good dose drug solution manufacturing, packaging, microbiology, cGMP biostorage, environmental checking, and pharmaceutical support services. Alcami’s non-public equity possession includes GHO Funds, The Vistria Team, and Ampersand Cash Companions. For a lot more facts, be sure to pay a visit to alcaminow.com.
Resource Alcami Company